{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:05:25Z","timestamp":1791893125804,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bpobgyn.2017.08.012","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T22:31:49Z","timestamp":1504650709000},"page":"73-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Secondary prevention of cervical cancer"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0124-4050","authenticated-orcid":false,"given":"Partha","family":"Basu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srabani","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diama","family":"Bhadra Vale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Chami Kharaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.012_bib1","first-page":"281","article-title":"Principles and practice of mass screening for disease","volume":"65","author":"Wilson","year":"1968","journal-title":"Bol Oficina Sanit Panam"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.012_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2471\/BLT.07.050112","article-title":"Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years","volume":"86","author":"Andermann","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.bpobgyn.2017.08.012_bib3","series-title":"GLOBOCAN 2012 v1.2, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]","author":"Ferlay","year":"2013"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.012_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 \u2013 2015: a systematic analysis for the global burden of disease study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.012_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.012_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2471\/BLT.07.050450","article-title":"Cervical cancer prevention and the millennium development goals","volume":"86","author":"Wittet","year":"2008","journal-title":"Bull World Health Organ"},{"issue":"6548","key":"10.1016\/j.bpobgyn.2017.08.012_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/bmj.293.6548.659","article-title":"Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies","volume":"293","year":"1986","journal-title":"Br Med J Clin Res Ed"},{"issue":"Suppl. 3","key":"10.1016\/j.bpobgyn.2017.08.012_bib8","article-title":"Chapter 7: achievements and limitations of cervical cytology screening","volume":"24","author":"Kitchener","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.012_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J\u00a0Pathol"},{"issue":"24","key":"10.1016\/j.bpobgyn.2017.08.012_bib10","doi-asserted-by":"crossref","first-page":"13174","DOI":"10.1128\/JVI.02172-12","article-title":"Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity","volume":"86","author":"White","year":"2012","journal-title":"J\u00a0Virol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.012_bib11","doi-asserted-by":"crossref","first-page":"E260","DOI":"10.1073\/pnas.1116776109","article-title":"Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses","volume":"109","author":"White","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.012_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/91.3.252","article-title":"Natural history of dysplasia of the uterine cervix","volume":"91","author":"Holowaty","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.012_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.012_bib14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnci\/91.3.226","article-title":"Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women","volume":"91","author":"Palefsky","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.012_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1086\/376996","article-title":"Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections","volume":"188","author":"Hawes","year":"2003","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.012_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/sj.bjc.6601017","article-title":"Risk of cancer in persons with AIDS in Italy, 1985\u20131998","volume":"89","author":"Dal","year":"2003","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.bpobgyn.2017.08.012_bib17","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/ijc.27793","article-title":"Prevalence of high-risk human papillomavirus and cervical intraepithelial neoplasias in a previously unscreened population\u2013a pooled analysis from three studies","volume":"132","author":"Basu","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2017.08.012_bib18","series-title":"Comprehensive cervical cancer control: a guide to essential practice","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.bpobgyn.2017.08.012_bib19","series-title":"Cancer screening in the European Union (2017)","author":"Ponti","year":"2017"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.012_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4321\/S0211-95362014000100006","article-title":"Viva Mulher: constructing a cervical cancer control program in Brazil","volume":"34","author":"Porto","year":"2014","journal-title":"Dynamis"},{"issue":"Suppl. 3","key":"10.1016\/j.bpobgyn.2017.08.012_bib21","doi-asserted-by":"crossref","first-page":"S388","DOI":"10.1590\/S0036-36342003000900013","article-title":"Improving cervical cancer screening in Mexico: results from the Morelos HPV Study","volume":"45","author":"Flores","year":"2003","journal-title":"Salud Publica Mex"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.012_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/ajcp\/99.1.45","article-title":"Cervicovaginal cytology, false-negative results, and standards of practice","volume":"99","author":"Dehner","year":"1993","journal-title":"Am J Clin Pathol"},{"issue":"9113","key":"10.1016\/j.bpobgyn.2017.08.012_bib23","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(05)79490-3","article-title":"Screening for cervical cancer","volume":"351","author":"Cuzick","year":"1998","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.bpobgyn.2017.08.012_bib24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/bjc.1996.196","article-title":"Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group","volume":"73","author":"Sasieni","year":"1996","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.012_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ijc.20396","article-title":"Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India","volume":"112","author":"Sankaranarayanan","year":"2004","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.012_bib26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.012_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"Suppl. 5","key":"10.1016\/j.bpobgyn.2017.08.012_bib28","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2017.08.012_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ijgo.12183","article-title":"Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings","volume":"138","author":"Basu","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.012_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijgo.2010.10.012","article-title":"Accuracy of visual inspection with acetic acid for cervical cancer screening","volume":"113","author":"Sauvaget","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.012_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/01.lgt.0000192694.85549.3d","article-title":"Inflation of sensitivity of cervical cancer screening tests secondary to correlated error in colposcopy","volume":"10","author":"Pretorius","year":"2006","journal-title":"J\u00a0Low Genit Tract Dis"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.012_bib32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ijc.29458","article-title":"Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India","volume":"137","author":"Basu","year":"2015","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.012_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122169","article-title":"Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia","volume":"10","author":"Parham","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.012_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.23489","article-title":"Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India","volume":"123","author":"Arbyn","year":"2008","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.bpobgyn.2017.08.012_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040766","article-title":"Knowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in Kenya","volume":"7","author":"Rositch","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.012_bib36","first-page":"604","article-title":"Cervical screening by visual inspection with acetic acid (VIA) is well accepted by women\u2013results from a community-based study in rural India","volume":"7","author":"Basu","year":"2006","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.012_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","article-title":"Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis","volume":"15","author":"Arbyn","year":"2014","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.012_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/sextrans-2016-052609","article-title":"The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis","volume":"93","author":"Nelson","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"16","key":"10.1016\/j.bpobgyn.2017.08.012_bib39","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.ejca.2015.07.006","article-title":"Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials","volume":"51","author":"Verdoodt","year":"2015","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.012_bib40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/096914139600300307","article-title":"Relation between the incidence of invasive cervical cancer and the screening interval: is a five year interval too long?","volume":"3","author":"Herbert","year":"1996","journal-title":"J\u00a0Med Screen"},{"issue":"7193","key":"10.1016\/j.bpobgyn.2017.08.012_bib41","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/bmj.318.7193.1244","article-title":"Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model","volume":"318","author":"Sasieni","year":"1999","journal-title":"BMJ"},{"issue":"9916","key":"10.1016\/j.bpobgyn.2017.08.012_bib42","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.bpobgyn.2017.08.012_bib43","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2017.08.012_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.bpobgyn.2017.08.012_bib45","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1055-9965.EPI-11-0206","article-title":"A\u00a0long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study","volume":"20","author":"Schiffman","year":"2011","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9585","key":"10.1016\/j.bpobgyn.2017.08.012_bib46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(07)61195-7","article-title":"Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial","volume":"370","author":"Sankaranarayanan","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.012_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju009","article-title":"Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India","volume":"106","author":"Shastri","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.012_bib48","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/ajo.12282","article-title":"Study of accuracy of colposcopy in VIA and HPV detection-based cervical cancer screening program","volume":"54","author":"Ghosh","year":"2014","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.012_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.AOG.0000295870.67752.b4","article-title":"Accuracy of colposcopy in the diagnostic setting compared with the screening setting","volume":"111","author":"Cantor","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.012_bib50","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bpobgyn.2011.04.007","article-title":"Management options for cervical intraepithelial neoplasia","volume":"25","author":"Petry","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.012_bib51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.012_bib52","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0002-9378(03)00418-6","article-title":"Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance","volume":"188","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.bpobgyn.2017.08.012_bib53","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/ijc.28900","article-title":"The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments","volume":"136","author":"Bergeron","year":"2015","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.012_bib54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/modpathol.2016.168","article-title":"Usefulness of p16INK4a staining for managing histological high-grade squamous intraepithelial cervical lesions","volume":"30","author":"Miralpeix","year":"2017","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.012_bib55","first-page":"210","article-title":"Morphometric study of intraepithelial neoplasia of the uterine cervix","volume":"60","author":"Abdul-Karim","year":"1982","journal-title":"Obstet Gynecol"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2017.08.012_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ijgo.12185","article-title":"Scaling up proven innovative cervical cancer screening strategies: challenges and opportunities in implementation at the population level in low- and lower-middle-income countries","volume":"138","author":"Holme","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.012_bib57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1471-0528.1991.tb10304.x","article-title":"Effective destruction of cervical intraepithelial neoplasia (CIN) 3 at 100 degrees C using the Semm cold coagulator: 14 years experience","volume":"98","author":"Gordon","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2017.08.012_bib58","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/1471-0528.12655","article-title":"Meta-analysis of the efficacy of cold coagulation as a treatment method for cervical intraepithelial neoplasia: a systematic review","volume":"121","author":"Dolman","year":"2014","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.012_bib59","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijgo.2015.07.026","article-title":"Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia","volume":"132","author":"Santesso","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.012_bib60","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cdp.2006.07.004","article-title":"Women's perceptions and social barriers determine compliance to cervical screening: results from a population based study in India","volume":"30","author":"Basu","year":"2006","journal-title":"Cancer Detect Prev"},{"issue":"20","key":"10.1016\/j.bpobgyn.2017.08.012_bib61","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/jnci\/djq342","article-title":"Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial","volume":"102","author":"Denny","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2017.08.012_bib62","series-title":"Disease control priorities in developing Countries","first-page":"3","article-title":"Disease control priorities in developing countries: an overview","author":"Jamison","year":"1993"},{"issue":"24","key":"10.1016\/j.bpobgyn.2017.08.012_bib63","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1001\/jama.285.24.3107","article-title":"Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness","volume":"285","author":"Goldie","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2017.08.012_bib64","series-title":"Scaling up action against non-communicable diseases: how much will it cost?","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.bpobgyn.2017.08.012_bib65","series-title":"A\u00a0phase 2a, multi-centre, randomised, double-blinded, parallel group, placebo-controlled study to evaluate efficacy, safety and tolerability of Inhaled GRC 17536, administered for 4 weeks, in patients with refractory chronic cough","author":"EU Clinical Trial Register","year":"2017"},{"key":"10.1016\/j.bpobgyn.2017.08.012_bib66","series-title":"Compass \u2013 randomised controlled trial of primary HPV testing for cervical screening in Australia","author":"Australian Clinical Trials","year":"2017"},{"issue":"10","key":"10.1016\/j.bpobgyn.2017.08.012_bib67","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/ijc.30579","article-title":"Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice","volume":"140","author":"Wentzensen","year":"2017","journal-title":"Int J Cancer"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169341730130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169341730130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T20:21:32Z","timestamp":1535401292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169341730130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":67,"alternative-id":["S152169341730130X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.012","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary prevention of cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}